Taxonomizing, sizing, and overcoming the incidentalome

Genetics in Medicine

Volumn 14, Issue 4, 2012, Pages 399-404

  Kohane, Isaac S ^a,b   Hsing, Michael ^a,b   Kong, Sek Won ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Harvard Medical School Center for Biomedical Informatics   (United States)

Author keywords

clinical interpretation; false positives; incidental findings; whole genome sequencing

Indexed keywords

ANALYTICAL ERROR; ARTICLE; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC DATABASE; GENETIC VARIABILITY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOSITY; HUMAN; INCIDENTAL FINDING; MOLECULAR GENETICS; NONSYNONYMOUS MUTATION; NUCLEOTIDE SEQUENCE; TAXONOMY;

FALSE POSITIVE REACTIONS; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HUMANS; INCIDENTAL FINDINGS; REPRODUCIBILITY OF RESULTS; RESEARCH SUBJECTS; SEQUENCE ANALYSIS, DNA; TRUTH DISCLOSURE;

EID: 84859561085     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2011.68     Document Type: Article

References (41)

1. Wheeler DA, Srinivasan M, Egholm M, et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008;452: 872-876. (Pubitemid 351550870)
2. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA 2006;296:212-215. (Pubitemid 44050375)
3. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218. (Pubitemid 34113819)
4. Beutler E. Carrier screening for Gaucher disease: more harm than good? JAMA 2007;298:1329-1331. (Pubitemid 47443347)
5. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009;461:724-726.
6. Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36(2):219-248, 211.
7. Drmanac R, Sparks AB, Callow MJ, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010;327:78-81.
8. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29:308-311. (Pubitemid 32054478)
9. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010;467(7319): 1061-1073.
10. Li Y, Vinckenbosch N, Tian G, et al. Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet 2010;42:969-972.
11. Danecek P, Auton A, Abecasis G, et al.; 1000 Genomes Project Analysis Group. The variant call format and VCFtools. Bioinformatics 2011;27:2156-2158.
12. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010;11: 415-425.
13. Liu X, Jian X, Boerwinkle E. dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat 2011;32:894-899.
14. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non- synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-1081.
15. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249.
16. González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 2011;88:440-449.
17. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A; NISC Comparative Sequencing Program. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005;15:901-913. (Pubitemid 40994210)
18. Tong MY, Cassa CA, Kohane IS. Automated validation of genetic variants from large databases: ensuring that variant references refer to the same genomic locations. Bioinformatics 2011:27(6);891-893.
19. Cooper DN, Stenson PD, Chuzhanova NA. The Human Gene Mutation Database (HGMD) and its exploitation in the study of mutational mechanisms. Curr Protoc Bioinformatics 2006;Chapter 1:Unit 1 13.
20. Pearson P, Francomano C, Foster P, Bocchini C, Li P, McKusick V. The status of online Mendelian inheritance in man (OMIM) medio 1994. Nucleic Acids Res 1994;22:3470-3473. (Pubitemid 24299808)
21. Hewett M, Oliver DE, Rubin DL, et al. PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res 2002;30:163-165. (Pubitemid 34679530)
22. Howard HJ, Horaitis O, Cotton RG, et al. The Human Variome Project (HVP) 2009 Forum "Towards Establishing Standards". Hum Mutat 2010;31(3):366-367.
23. Stokes T. Businesses ready whole-genome analysis services for researchers. Nat Med 2011;17:1161.
24. Harismendy O, Ng PC, Strausberg RL, et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 2009;10:R32.
25. Benaglio P, Rivolta C. Ultra high throughput sequencing in human DNA variation detection: a comparative study on the NDUFA3-PRPF31 region. PLoS ONE 2010;5:e13071.
26. Zhang W, Chen J, Yang Y, Tang Y, Shang J, Shen B. A practical comparison of de novo genome assembly software tools for next-generation sequencing technologies. PLoS ONE 2011;6:e17915.
27. Bentley DR, Balasubramanian S, Swerdlow HP, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008;456:53-59.
28. Moore B, Hu H, Singleton M, Reese MG, De La Vega FM, Yandell M. Global analysis of disease-related DNA sequence variation in 10 healthy individuals: implications for whole genome-based clinical diagnostics. Genet Med 2011;13:210-217.
29. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultralong oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-189.
30. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22:187-194; discussion 194a.
31. Fleming RE, Holden CC, Tomatsu S, et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci USA 2001;98:2707-2711. (Pubitemid 32209547)
32. Scotet V, Mérour MC, Mercier AY, et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 2003;158:129-134. (Pubitemid 36841944)
33. Begg CB, Haile RW, Borg A, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008;299:194-201.
34. Domchek SM. Refining BRCA1 and BRCA2 penetrance estimates in the clinic. Current Breast Cancer Reports 2009;1:127-130.
35. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011;13:499-504.
36. Kohane IS. Using electronic health records to drive discovery in disease genomics. Nat Rev Genet 2011;12:417-428.
37. Szolovits P, Pauker SG. Categorical and probabilistic reasoning in medical diagnosis. Artificial Intelligence in Medicine 1978;11:115-144. (Pubitemid 9397515)
38. Altman RB. Direct-to-consumer genetic testing: failure is not an option. Clin Pharmacol Ther 2009;86:15-17.
39. Church GM. The personal genome project. Mol Syst Biol 2005;1:2005.0030.
40. Kohane IS, Mandl KD, Taylor PL, Holm IA, Nigrin DJ, Kunkel LM. Medicine. Reestablishing the researcher-patient compact. Science 2007;316: 836-837.
41. Kohane IS, Taylor PL. Multidimensional results reporting to participants in genomic studies: getting it right. Sci Transl Med 2010;2(37):37cm19.